Mithramycin A inhibits colorectal cancer growth by targeting cancer stem cells W Quarni, R Dutta, R Green, S Katiri, B Patel, SS Mohapatra, S Mohapatra Scientific reports 9 (1), 15202, 2019 | 61 | 2019 |
A MAPK/miR-29 axis suppresses melanoma by targeting MAFG and MYBL2 O Vera, I Bok, N Jasani, K Nakamura, X Xu, N Mecozzi, A Angarita, ... Cancers 13 (6), 1408, 2021 | 27 | 2021 |
Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis M Mooring, GA Yeung, P Luukkonen, S Liu, MW Akbar, GJ Zhang, ... Science translational medicine 15 (715), eade3157, 2023 | 8 | 2023 |
Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs O Balogun, K Nejak-Bowen Seminars in Liver Disease, 2024 | 2 | 2024 |
The hepatic porphyrias: revealing the complexities of a rare disease O Balogun, K Nejak-Bowen Seminars in Liver Disease, 2023 | 1 | 2023 |
Loss of β-catenin reveals a role for glutathione in regulating oxidative stress during cholestatic liver disease O Balogun, D Shao, M Carson, T King, K Kosar, R Zhang, G Zeng, ... Hepatology Communications 8 (7), e0485, 2024 | | 2024 |
THE ROLE OF BETA-CATENIN IN REGULATING AUTOPHAGY DURING PORPHYRIA A Balogun, K Nejak-Bowen HEPATOLOGY 78, S1997-S1998, 2023 | | 2023 |
CYR61 ORCHESTRATES NASH FIBROSIS THROUGH AN IRAK4-SYK-NF kappa B-PDGF SIGNALING AXIS M Mooring, P Luukkonen, S Liu, A Balogun, X Yu, R Mo, K Nejak-Bowen, ... HEPATOLOGY 76, S621-S622, 2022 | | 2022 |
Beta‐catenin inhibition as a novel therapeutic strategy for porphyria A Balogun, P Cornuet, K Nejak‐Bowen The FASEB Journal 36, 2022 | | 2022 |
Abstract PR12: Regulation of the tumor-suppressive miR-29 family by oncogenic MAPK signaling in melanoma O Vera, I Bok, N Jasani, O Balogun, K Nakamura, F Karreth Cancer Research 80 (19_Supplement), PR12-PR12, 2020 | | 2020 |
Regulation of the tumor-suppressive miR-29 family by oncogenic MAPK signaling in melanoma. O Vera, I Bok, N Jasani, O Balogun, K Nakamura, F Karreth CANCER RESEARCH 80 (19), 54-54, 2020 | | 2020 |